Bio-Technology General Corp. to Release 2001 Earnings Results and Host Webcast On February 21, 2002.Business Editors ISELIN, N.J.--(BUSINESS WIRE)--Feb. 15, 2002 Bio-Technology General Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BTGC) will announce its 2001 earnings results for the fourth quarter and year-ended December 31, 2001 on Thursday, February 21, 2002, before the market open. The announcement will be followed by a live webcast discussion, hosted by BTG management, of the earnings and an update of the Company's business at 11:00 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy . The webcast can be accessed at www.btgc.com, BTG's website, and will be archived through February 28, 2002. An audio replay will also be available from February 21, 2002 after 1:00 p.m. EST through February 28, 2002 and can be accessed by dialing 800-428-6051 (in the U.S.) or 973-709-2089 (from overseas); passcode number is 231863. Bio-Technology General Corp., a leading biopharmaceutical company, develops, manufactures and markets genetically engineered and other products for human health care. BTG's products are marketed worldwide. Products sold in the United States are Oxandrin(R) (oxandrolone, USP), marketed by BTG and by the Ross Products Division of Abbott Laboratories under a co-promotion agreement, Delatestryl(R) (testosterone enanthate), marketed by BTG, Mircette(TM) (oral contraceptive), marketed by Organon, Inc., and BioLon(TM) (sodium hyaluronate hyaluronate /hy·al·uro·nate/ (hi?ah-ldbobr´ro-nat) a salt, anion, or ester of hyaluronic acid. The sodium salt and a derivative of it are used as analgesics in the treatment of osteoarthritis of the knee. ), marketed by Akorn, Inc. Products sold internationally are Bio-Tropin(TM) (recombinant human growth hormone human growth hormone (HGH): see growth hormone. ), BioLon(TM) (sodium hyaluronate), Bio-Hep-B(TM) (hepatitis B vaccine hepatitis B vaccine n. Abbr. HB A vaccine prepared from the inactivated surface antigen of the hepatitis B virus and used to immunize against hepatitis B. ), Silkis(R) (vitamin D derivative), Arthrease(TM) (sodium hyaluronate for osteoarthritis), and recombinant human insulin Noun 1. recombinant human insulin - a form of insulin (trade name Humulin) made from recombinant DNA that is identical to human insulin; used to treat diabetics who are allergic to preparations made from beef or pork insulin Humulin for diabetes. BTG's news releases and other information are available on the Company's website at www.btgc.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion